NGNE
NGNE
NASDAQ · Biotechnology

Neurogene Inc

$21.23
+1.07 (+5.31%)
As of Apr 1, 2:16 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +18.4% upside
Low Target $17.03
Average Target $25.14
High Target $37.02
Current Price $21.23
Current
$21.23
Target
$25.14
$17.03 $25.14 avg $37.02
Scenario Analysis
Bear Case
$17.03
-19.8%
Low target
Base Case
$25.14
+18.4%
Avg target
Bull Case
$37.02
+74.4%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$37.27
-43.0% from high
52-Week Low
$6.88
+208.8% from low
Target vs 52W High
$25.14
-32.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%